Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Iron chelation refers to the process of binding excess iron in the body using specific molecules (chelators) that form stable complexes with iron, allowing its safe removal from tissues and subsequent excretion. This is a therapeutic strategy primarily used to treat conditions of iron overload, where excess iron can accumulate due to repeated blood transfusions or genetic disorders affecting iron metabolism.
Formation of stable Fe³⁺-chelator complexes, preventing iron from participating in harmful redox reactions and facilitating its excretion.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Iron chelation.